Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "2022"

1455 News Found

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
News | August 10, 2023

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr

Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023


Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
News | August 10, 2023

Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr

Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023


Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
News | August 10, 2023

Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr

Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023


Abbott India's Q1 FY24 PAT up at Rs. 290.24 Cr
News | August 10, 2023

Abbott India's Q1 FY24 PAT up at Rs. 290.24 Cr

Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023


IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr
News | August 10, 2023

IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr

IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023


Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr
News | August 10, 2023

Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr

Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023


Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
News | August 09, 2023

Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr

US FDA approval is in line with de-risking strategy for additional API site to service our global customer base


KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr
News | August 08, 2023

KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr

KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023


Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
News | August 08, 2023

Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr

Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023